Literature DB >> 28985983

Medical and Surgical Management of Equine Recurrent Uveitis.

Richard Joseph McMullen1, Britta Maria Fischer2.   

Abstract

Equine recurrent uveitis (ERU) is characterized by recurrent bouts of inflammation interrupted by periods of quiescence that vary in duration. There is little consensus on the clinical manifestations, the underlying causes, or the management. The 3 commonly recognized syndromes of ERU (classic, insidious, and posterior) do not accurately separate the clinical manifestations of disease into distinct categories. An accurate diagnosis and early intervention are essential to minimizing the effects of disease and preserving vision. There are multiple medical and surgical options for controlling ERU as long as the disease is recognized early and targeted treatment is initiated immediately.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cyclosporine implant; Equine recurrent uveitis; Gentamicin; Intravitreal injection; Vitrectomy

Mesh:

Year:  2017        PMID: 28985983     DOI: 10.1016/j.cveq.2017.07.003

Source DB:  PubMed          Journal:  Vet Clin North Am Equine Pract        ISSN: 0749-0739            Impact factor:   1.792


  6 in total

Review 1.  A comprehensive review of intravitreal immunosuppressants and biologicals used in ophthalmology.

Authors:  Nasiq Hasan; Rohan Chawla; Nawazish Shaikh; Sindhuja Kandasamy; Shorya Vardhan Azad; M Dheepak Sundar
Journal:  Ther Adv Ophthalmol       Date:  2022-05-18

2.  Horses with equine recurrent uveitis have an activated CD4+ T-cell phenotype that can be modulated by mesenchymal stem cells in vitro.

Authors:  Laurel K Saldinger; Seldy G Nelson; Rebecca R Bellone; Mary Lassaline; Maura Mack; Naomi J Walker; Dori L Borjesson
Journal:  Vet Ophthalmol       Date:  2019-08-22       Impact factor: 1.644

Review 3.  Immunological Insights in Equine Recurrent Uveitis.

Authors:  Roxane L Degroote; Cornelia A Deeg
Journal:  Front Immunol       Date:  2021-01-08       Impact factor: 7.561

4.  Plasma atropine concentrations associated with decreased intestinal motility in horses.

Authors:  Carl Ekstrand; Peter Michanek; Ronette Gehring; Anna Sundell; Annika Källse; Mikael Hedeland; Lena Ström
Journal:  Front Vet Sci       Date:  2022-09-02

5.  Penetration of topically administered dexamethasone disodium phosphate and prednisolone acetate into the normal equine ocular fluids.

Authors:  Hanneke Hermans; Els M H van den Berg; Inge J M Slenter; Dax J C Vendrig; Lilian J L de Nijs-Tjon; Johannes C M Vernooij; Harold Brommer; Michael H Boevé; Ronette Gehring
Journal:  Equine Vet J       Date:  2021-11-21       Impact factor: 2.692

6.  Clinical utility, dose determination, and safety of ocular contrast-enhanced ultrasonography in horses: A pilot study.

Authors:  Klaas-Ole Blohm; Alexander Tichy; Barbara Nell
Journal:  Vet Ophthalmol       Date:  2019-12-04       Impact factor: 1.644

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.